INmune Bio Inc. was originally incorporated in Nevada on September 25, 2015. The company's goal is to develop and commercialize products to treat diseases in which the innate immune system does not work properly or is caused by it. These diseases include cancer, where the lack of activity of NK cells causes the tumor to evade the immune system, MDSCs proliferate to protect the tumor from the patient's immune system, and chronic infections such as dysfunction or other neurological and metabolic diseases, and metabolic diseases caused by chronic inflammation. INmune Bio Inc .'s initial focus is on the treatment of cancer - hematological malignancies and solid tumors. 

INMB

INMB Profile